Annual CFO:
-$492.60M-$4.03B(-113.93%)Summary
- As of today, VRTX annual cash from operations is -$492.60 million, with the most recent change of -$4.03 billion (-113.93%) on December 31, 2024.
- During the last 3 years, VRTX annual cash from operations has fallen by -$3.14 billion (-118.63%).
- VRTX annual cash from operations is now -111.93% below its all-time high of $4.13 billion, reached on December 31, 2022.
Performance
VRTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$1.24B+$168.30M(+15.68%)Summary
- As of today, VRTX quarterly cash from operations is $1.24 billion, with the most recent change of +$168.30 million (+15.68%) on September 30, 2025.
- Over the past year, VRTX quarterly cash from operations has dropped by -$128.40 million (-9.37%).
- VRTX quarterly cash from operations is now -9.37% below its all-time high of $1.37 billion, reached on September 30, 2024.
Performance
VRTX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$3.72B-$128.40M(-3.34%)Summary
- As of today, VRTX TTM cash from operations is $3.72 billion, with the most recent change of -$128.40 million (-3.34%) on September 30, 2025.
- Over the past year, VRTX TTM cash from operations has increased by +$4.56 billion (+541.25%).
- VRTX TTM cash from operations is now -15.14% below its all-time high of $4.38 billion, reached on September 30, 2023.
Performance
VRTX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VRTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -113.9% | -9.4% | +541.3% |
| 3Y3 Years | -118.6% | +29.9% | -8.1% |
| 5Y5 Years | -131.4% | +36.8% | +15.9% |
VRTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -111.9% | at low | -9.4% | +133.1% | -15.1% | +479.3% |
| 5Y | 5-Year | -111.9% | at low | -9.4% | +133.1% | -15.1% | +479.3% |
| All-Time | All-Time | -111.9% | +22.5% | -9.4% | +133.1% | -15.1% | +479.3% |
VRTX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1.24B(+15.7%) | $3.72B(-3.3%) |
| Jun 2025 | - | $1.07B(+31.0%) | $3.85B(+492.4%) |
| Mar 2025 | - | $818.90M(+40.1%) | -$980.30M(-99.0%) |
| Dec 2024 | -$492.60M(-113.9%) | $584.60M(-57.3%) | -$492.60M(+41.5%) |
| Sep 2024 | - | $1.37B(+136.5%) | -$842.60M(+10.7%) |
| Jun 2024 | - | -$3.75B(-387.3%) | -$944.00M(-123.9%) |
| Mar 2024 | - | $1.31B(+456.9%) | $3.94B(+11.5%) |
| Dec 2023 | $3.54B(-14.3%) | $234.60M(-81.5%) | $3.54B(-19.3%) |
| Sep 2023 | - | $1.27B(+11.8%) | $4.38B(+7.7%) |
| Jun 2023 | - | $1.13B(+26.1%) | $4.07B(-0.1%) |
| Mar 2023 | - | $899.90M(-16.6%) | $4.07B(-1.4%) |
| Dec 2022 | $4.13B(+56.2%) | $1.08B(+12.9%) | $4.13B(+2.1%) |
| Sep 2022 | - | $955.50M(-16.2%) | $4.05B(+0.7%) |
| Jun 2022 | - | $1.14B(+19.2%) | $4.02B(+50.0%) |
| Mar 2022 | - | $956.20M(-3.9%) | $2.68B(+1.3%) |
| Dec 2021 | $2.64B(-18.7%) | $994.99M(+7.3%) | $2.64B(+23.5%) |
| Sep 2021 | - | $927.22M(+564.2%) | $2.14B(+0.9%) |
| Jun 2021 | - | -$199.77M(-121.7%) | $2.12B(-36.9%) |
| Mar 2021 | - | $921.05M(+87.4%) | $3.36B(+3.2%) |
| Dec 2020 | $3.25B(+107.3%) | $491.53M(-45.9%) | $3.25B(+1.4%) |
| Sep 2020 | - | $907.75M(-12.6%) | $3.21B(+21.7%) |
| Jun 2020 | - | $1.04B(+27.3%) | $2.64B(+27.9%) |
| Mar 2020 | - | $815.70M(+82.9%) | $2.06B(+31.3%) |
| Dec 2019 | $1.57B(+23.5%) | $446.01M(+33.2%) | $1.57B(+9.1%) |
| Sep 2019 | - | $334.79M(-27.8%) | $1.44B(-3.1%) |
| Jun 2019 | - | $463.75M(+42.8%) | $1.48B(+10.6%) |
| Mar 2019 | - | $324.78M(+3.2%) | $1.34B(+5.7%) |
| Dec 2018 | $1.27B(+50.3%) | $314.58M(-17.5%) | $1.27B(+7.4%) |
| Sep 2018 | - | $381.35M(+18.5%) | $1.18B(+21.7%) |
| Jun 2018 | - | $321.70M(+27.3%) | $971.96M(+16.8%) |
| Mar 2018 | - | $252.66M(+11.1%) | $831.91M(-1.5%) |
| Dec 2017 | $844.94M(+257.9%) | $227.51M(+33.8%) | $844.94M(+10.9%) |
| Sep 2017 | - | $170.09M(-6.4%) | $762.15M(+15.9%) |
| Jun 2017 | - | $181.65M(-31.6%) | $657.73M(+27.2%) |
| Mar 2017 | - | $265.69M(+83.6%) | $516.93M(+118.9%) |
| Dec 2016 | $236.10M(+164.6%) | $144.72M(+120.4%) | $236.10M(+213.3%) |
| Sep 2016 | - | $65.66M(+60.7%) | $75.36M(+302.0%) |
| Jun 2016 | - | $40.86M(+369.9%) | -$37.31M(+78.5%) |
| Mar 2016 | - | -$15.14M(+5.5%) | -$173.39M(+52.6%) |
| Dec 2015 | -$365.43M(+28.8%) | -$16.01M(+65.9%) | -$365.43M(+22.5%) |
| Sep 2015 | - | -$47.02M(+50.6%) | -$471.29M(+7.9%) |
| Jun 2015 | - | -$95.21M(+54.0%) | -$511.91M(+6.0%) |
| Mar 2015 | - | -$207.18M(-70.0%) | -$544.62M(-6.1%) |
| Dec 2014 | -$513.20M(-895.2%) | -$121.87M(-39.0%) | -$513.20M(-41.6%) |
| Sep 2014 | - | -$87.65M(+31.5%) | -$362.47M(-25.6%) |
| Jun 2014 | - | -$127.92M(+27.2%) | -$288.55M(-78.6%) |
| Mar 2014 | - | -$175.76M(-709.1%) | -$161.55M(-213.3%) |
| Dec 2013 | -$51.57M(-119.3%) | $28.86M(+310.3%) | -$51.57M(-29.4%) |
| Sep 2013 | - | -$13.72M(-1380.0%) | -$39.87M(-149.9%) |
| Jun 2013 | - | -$927.00K(+98.6%) | $79.81M(-59.9%) |
| Mar 2013 | - | -$65.78M(-262.2%) | $199.15M(-25.6%) |
| Dec 2012 | $267.84M(+86.3%) | $40.56M(-61.7%) | $267.84M(-63.4%) |
| Sep 2012 | - | $105.96M(-10.5%) | $730.95M(+9.4%) |
| Jun 2012 | - | $118.41M(+3960.5%) | $667.88M(+100.4%) |
| Mar 2012 | - | $2.92M(-99.4%) | $333.28M(+131.9%) |
| Dec 2011 | $143.74M(+122.6%) | $503.66M(+1074.2%) | $143.74M(+127.3%) |
| Sep 2011 | - | $42.90M(+119.8%) | -$526.03M(+28.2%) |
| Jun 2011 | - | -$216.19M(-15.8%) | -$732.92M(-17.2%) |
| Mar 2011 | - | -$186.63M(-12.4%) | -$625.61M(+1.5%) |
| Dec 2010 | -$635.44M(-48.6%) | -$166.10M(-1.3%) | -$635.44M(-11.2%) |
| Sep 2010 | - | -$163.99M(-50.6%) | -$571.67M(-33.2%) |
| Jun 2010 | - | -$108.89M(+44.6%) | -$429.31M(+2.1%) |
| Mar 2010 | - | -$196.46M(-92.0%) | -$438.49M(-2.5%) |
| Dec 2009 | -$427.59M(-88.8%) | -$102.33M(-373.0%) | -$427.59M(-1.2%) |
| Sep 2009 | - | -$21.64M(+81.7%) | -$422.48M(+20.0%) |
| Jun 2009 | - | -$118.06M(+36.4%) | -$528.33M(-72.4%) |
| Mar 2009 | - | -$185.56M(-90.9%) | -$306.51M(-35.3%) |
| Dec 2008 | -$226.48M | -$97.22M(+23.7%) | -$226.48M(-24.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | -$127.48M(-222.9%) | -$181.95M(-54.1%) |
| Jun 2008 | - | $103.76M(+198.3%) | -$118.11M(+59.3%) |
| Mar 2008 | - | -$105.53M(-100.3%) | -$290.20M(-14.9%) |
| Dec 2007 | -$252.48M(-1023.4%) | -$52.69M(+17.2%) | -$252.48M(-23.8%) |
| Sep 2007 | - | -$63.64M(+6.9%) | -$203.90M(-426.7%) |
| Jun 2007 | - | -$68.33M(-0.8%) | -$38.71M(-31.6%) |
| Mar 2007 | - | -$67.81M(-1547.0%) | -$29.41M(-30.9%) |
| Dec 2006 | -$22.48M(+86.9%) | -$4.12M(-104.1%) | -$22.48M(+11.3%) |
| Sep 2006 | - | $101.55M(+272.0%) | -$25.33M(+86.2%) |
| Jun 2006 | - | -$59.04M(+3.0%) | -$183.24M(-2.9%) |
| Mar 2006 | - | -$60.87M(-772.8%) | -$178.11M(-3.5%) |
| Dec 2005 | -$172.07M(-21.0%) | -$6.97M(+87.6%) | -$172.07M(+8.8%) |
| Sep 2005 | - | -$56.36M(-4.5%) | -$188.74M(-7.2%) |
| Jun 2005 | - | -$53.91M(+1.7%) | -$176.06M(-21.3%) |
| Mar 2005 | - | -$54.83M(-131.9%) | -$145.12M(-2.1%) |
| Dec 2004 | -$142.16M(+15.2%) | -$23.64M(+45.9%) | -$142.16M(+3.4%) |
| Sep 2004 | - | -$43.67M(-90.1%) | -$147.22M(+3.2%) |
| Jun 2004 | - | -$22.97M(+55.7%) | -$152.08M(+10.2%) |
| Mar 2004 | - | -$51.87M(-80.7%) | -$169.42M(-1.1%) |
| Dec 2003 | -$167.62M(-110.7%) | -$28.70M(+40.9%) | -$167.62M(-10.0%) |
| Sep 2003 | - | -$48.53M(-20.4%) | -$152.40M(-24.8%) |
| Jun 2003 | - | -$40.32M(+19.5%) | -$122.15M(-23.0%) |
| Mar 2003 | - | -$50.07M(-271.6%) | -$99.33M(-24.9%) |
| Dec 2002 | -$79.54M(-885.1%) | -$13.48M(+26.3%) | -$79.54M(-234.1%) |
| Sep 2002 | - | -$18.29M(-4.5%) | -$23.81M(+46.6%) |
| Jun 2002 | - | -$17.50M(+42.2%) | -$44.58M(-49.4%) |
| Mar 2002 | - | -$30.28M(-171.7%) | -$29.83M(-269.5%) |
| Dec 2001 | -$8.07M(+51.5%) | $42.26M(+208.2%) | -$8.07M(+87.4%) |
| Sep 2001 | - | -$39.06M(-1321.9%) | -$64.15M(-81.5%) |
| Jun 2001 | - | -$2.75M(+67.8%) | -$35.34M(-267.4%) |
| Mar 2001 | - | -$8.52M(+38.3%) | -$9.62M(+42.2%) |
| Dec 2000 | -$16.64M(+47.7%) | -$13.82M(-34.9%) | -$16.64M(-360.8%) |
| Sep 2000 | - | -$10.25M(-144.6%) | $6.38M(+105.0%) |
| Jun 2000 | - | $22.98M(+247.8%) | $3.11M(+109.6%) |
| Mar 2000 | - | -$15.55M(-268.9%) | -$32.49M(-2.1%) |
| Dec 1999 | -$31.81M(-2.4%) | $9.20M(+168.1%) | -$31.81M(+38.6%) |
| Sep 1999 | - | -$13.52M(-7.1%) | -$51.80M(-39.0%) |
| Jun 1999 | - | -$12.62M(+15.1%) | -$37.28M(-10.6%) |
| Mar 1999 | - | -$14.87M(-37.8%) | -$33.72M(-8.6%) |
| Dec 1998 | -$31.05M(-231.7%) | -$10.79M(-1173.0%) | -$31.05M(-30.7%) |
| Sep 1998 | - | $1.01M(+111.1%) | -$23.76M(+13.8%) |
| Jun 1998 | - | -$9.06M(+25.8%) | -$27.57M(-45.8%) |
| Mar 1998 | - | -$12.21M(-248.7%) | -$18.91M(-101.1%) |
| Dec 1997 | -$9.36M(+76.7%) | -$3.50M(-25.0%) | -$9.40M(-6.8%) |
| Sep 1997 | - | -$2.80M(-600.0%) | -$8.80M(+31.8%) |
| Jun 1997 | - | -$400.00K(+85.2%) | -$12.90M(+62.8%) |
| Mar 1997 | - | -$2.70M(+6.9%) | -$34.70M(+13.9%) |
| Dec 1996 | -$40.25M(-152.4%) | -$2.90M(+58.0%) | -$40.30M(-8.6%) |
| Sep 1996 | - | -$6.90M(+68.9%) | -$37.10M(-7.2%) |
| Jun 1996 | - | -$22.20M(-167.5%) | -$34.60M(-79.3%) |
| Mar 1996 | - | -$8.30M(-2866.7%) | -$19.30M(-20.6%) |
| Dec 1995 | -$15.95M(-8.6%) | $300.00K(+106.8%) | -$16.00M(+26.3%) |
| Sep 1995 | - | -$4.40M(+36.2%) | -$21.70M(-9.0%) |
| Jun 1995 | - | -$6.90M(-38.0%) | -$19.90M(-22.8%) |
| Mar 1995 | - | -$5.00M(+7.4%) | -$16.20M(-10.2%) |
| Dec 1994 | -$14.68M(-270.1%) | -$5.40M(-107.7%) | -$14.70M(-1570.0%) |
| Sep 1994 | - | -$2.60M(+18.8%) | $1.00M(-73.0%) |
| Jun 1994 | - | -$3.20M(+8.6%) | $3.70M(-47.1%) |
| Mar 1994 | - | -$3.50M(-134.0%) | $7.00M(-18.6%) |
| Dec 1993 | $8.63M(+262.0%) | $10.30M(>+9900.0%) | $8.60M(+368.8%) |
| Sep 1993 | - | $100.00K(0.0%) | -$3.20M(+31.9%) |
| Jun 1993 | - | $100.00K(+105.3%) | -$4.70M(+19.0%) |
| Mar 1993 | - | -$1.90M(-26.7%) | -$5.80M(-9.4%) |
| Dec 1992 | -$5.33M(-111.1%) | -$1.50M(-7.1%) | -$5.30M(-39.5%) |
| Sep 1992 | - | -$1.40M(-40.0%) | -$3.80M(-58.3%) |
| Jun 1992 | - | -$1.00M(+28.6%) | -$2.40M(-71.4%) |
| Mar 1992 | - | -$1.40M | -$1.40M |
| Dec 1991 | -$2.52M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual cash from operations?
- What is the all-time high annual cash from operations for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual cash from operations year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly cash from operations year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM cash from operations?
- What is the all-time high TTM cash from operations for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM cash from operations year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual cash from operations?
The current annual cash from operations of VRTX is -$492.60M
What is the all-time high annual cash from operations for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual cash from operations is $4.13B
What is Vertex Pharmaceuticals Incorporated annual cash from operations year-on-year change?
Over the past year, VRTX annual cash from operations has changed by -$4.03B (-113.93%)
What is Vertex Pharmaceuticals Incorporated quarterly cash from operations?
The current quarterly cash from operations of VRTX is $1.24B
What is the all-time high quarterly cash from operations for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly cash from operations is $1.37B
What is Vertex Pharmaceuticals Incorporated quarterly cash from operations year-on-year change?
Over the past year, VRTX quarterly cash from operations has changed by -$128.40M (-9.37%)
What is Vertex Pharmaceuticals Incorporated TTM cash from operations?
The current TTM cash from operations of VRTX is $3.72B
What is the all-time high TTM cash from operations for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM cash from operations is $4.38B
What is Vertex Pharmaceuticals Incorporated TTM cash from operations year-on-year change?
Over the past year, VRTX TTM cash from operations has changed by +$4.56B (+541.25%)